Limited Liability Company (LLC)
Polpharma Biologics Warsaw
Polpharma Biologics Warsaw Spółka z Ograniczoną Odpowiedzialnością
Polpharma Biologics Warsaw Spółka z Ograniczoną Odpowiedzialnością (KRS 0000498732, NIP 1182096979) is a Polish company, headquartered in Duchnice, Mazowieckie voivodeship. Polpharma Biologics Warsaw operates in: Rental and operating of own or leased real estate (PKD 68.20.Z). Industry: Real estate. The company has been listed in the National Court Register since February 20, 2014. Polpharma Biologics Warsaw's most recently reported net revenue was 113.6 M PLN for 2021.
No arrears identified in the analysed sources
No arrears or bankruptcy proceedings identified in the analysed sources.
Other activities
Credibility rating
40.4 / 100
Average credibility
Insolvency risk
Very low
Elevated threat
Closure risk
30
/ 100
Risk comparison - scale 0 (safe) → 100 (critical)
Spółka wykazuje sygnały niestabilności organizacyjnej: częste zmiany właścicieli. Może to wskazywać na podwyższone ryzyko współpracy.
Shareholder changes
9
9/12 yrs
Board changes
5
5/12 yrs
PKD changes
2
2/12 yrs
Name changes
1
1/12 yrs
Data from 12 years of registry activity.
Payment reliability score from 2020–2021
Current: D (40/100)
Trend: stable (+0.3 pts/year)
Słaba wiarygodność płatnicza – wskaźniki finansowe sugerują podwyższone ryzyko opóźnień lub niewykonania zobowiązań.
Standard limit from 2020–2021
Current: 13.7 M PLN
Safe: 4.1 M PLN
Difference between risk models
Closure - probability of ceasing operations (operational continuity). Insolvency - probability of formal bankruptcy / restructuring. The models use different data - results can diverge significantly when balance-sheet data is incomplete.
Founded
February 20, 2014
12 years in operation
Legal form
Limited Liability Company (LLC)
Registry: RejP
Headquarters
DUCHNICE
MAZOWIECKIE
Primary PKD
68.20.Z
Rental and operating of own or leased real estate
Share capital
349.8 M PLN
349,835 shares total
Shareholders
1
shareholder
Board
2 people
Sup. board: 3
Filed years
2 years
2020–2021 · profitable: 0/2
Registry entries
60
latest: June 26, 2026
Risk signals
Revenue
113.6 M PLN
2021
Net profit
-119.0 M PLN
2021
Assets
621.8 M PLN
2021
Equity
421.4 M PLN
2021
EBITDA
N/A
2021
no depreciation data
Valuation
188.3 M PLN
Low confidence
Low confidence
People holding roles at Polpharma Biologics Warsaw according to the Polish National Court Register. Follow a name for that person's full profile and their other companies.
Rate business credibility - Polpharma Biologics Warsaw.
No ratings
Latest reporting year
2025
Available years
12
Filing entries
0
20 historical registry entries for Polpharma Biologics Warsaw
Filing documents submitted (4 documents)
Filing documents submitted (4 documents)
Change in Section 1 (basic data)
WA.XIV NS-REJ.KRS/6988/23/122/ADE
Filing documents submitted (4 documents)
Filing documents submitted (4 documents)
Competing companies or those operating in the same market segment as Polpharma Biologics Warsaw (industry: Real estate).
KONIN· Real estate
Revenue 2024: 97.0 M PLN
WARSZAWA· Real estate
Revenue 2024: 63.4 M PLN
WARSZAWA· Real estate
Revenue 2021: 44.8 M PLN
WARSZAWA· Real estate
Revenue 2024: 39.5 M PLN
WARSZAWA· Real estate
Revenue 2024: 36.4 M PLN
WARSZAWA· Real estate
Revenue 2024: 28.8 M PLN
Limited Liability Company (LLC)
Polpharma Biologics Warsaw Spółka z Ograniczoną Odpowiedzialnością
Answers to questions about the company's activity, registered office, identifiers, financial data, capital and control.
Polpharma Biologics Warsaw has 1 shareholder.
Yes - Polpharma Biologics Warsaw's majority owner is WINDSTORM TRADING & INVESTMENTS LIMITED.
Polpharma Biologics Warsaw's board has 2 members.